Pain scores on the standard knee-osteoarthritis outcome measure (the WOMAC pain subscale) fell by an average of 4.5 points, around 75.8%
The FDA has issued cautions about reports of adverse events associated with compounded semaglutide, such as severe gastrointestinal difficulties and unanticipated side effects
The medications themselves are FDA-approved for specific indications (diabetes and/or obesity), but microdosing is an off-label dosing strategy used at physician discretion based on individual response and goals
Rather than overwhelming neurotransmitter systems, they replicate naturally occurring hormones that the body uses for normal appetite and metabolism regulation
No safety information exists for breastfeeding with these medications
Lillys Triple Agonist, Retatrutide, Delivered Powerful Weight Loss in Pivotal Phase 3 Obesity Trial